Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:34:18 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Q:PTCT - PTC THERAPEUTICS INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PTCT - Q0.147.68·87.501.274.68+2.323.21,040.576,24213,72073.77  75.00  72.6487.50  35.9518:50:03Feb 0515 min RT 2¢

Recent Trades - Last 10 of 13720
Time ETExPriceChangeVolume
18:50:03Q75.503.143
18:33:14Q74.512.154
18:33:14Q74.512.158
18:30:56Q75.383.021
18:29:51Q75.002.641
18:26:34Q74.902.541
18:26:34Q74.902.543
18:26:16Q75.012.651
18:25:55Q74.902.54100
18:25:46Q74.902.5480

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-05 08:00U:PTCTNews ReleasePTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026
2026-01-12 08:30U:PTCTNews ReleasePTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference
2026-01-08 16:30U:PTCTNews ReleasePTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-12-22 07:00U:PTCTNews ReleasePTC Therapeutics Announces Approval of Sephience(TM) (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan
2025-12-19 16:30U:PTCTNews ReleasePTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-12-18 08:00U:PTCTNews ReleasePTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
2025-12-10 08:00U:PTCTNews ReleasePTC Therapeutics Announces Health Canada Approval of Sephience(TM) (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU)
2025-12-01 16:30U:PTCTNews ReleasePTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-12-01 09:00U:PTCTNews ReleaseCadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors
2025-11-24 18:01U:PTCTNews ReleaseSandisk Set to Join S&P 500; Upwork, First Interstate BancSystem, PTC Therapeutics to Join S&P SmallCap 600
2025-11-20 08:00U:PTCTNews ReleasePTC Therapeutics to Host R&D Day
2025-11-04 16:01U:PTCTNews ReleasePTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
2025-10-31 08:00U:PTCTNews ReleasePTC Therapeutics to Participate at Upcoming Investor Conferences
2025-10-27 16:30U:PTCTNews ReleasePTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-10-21 08:00U:PTCTNews ReleasePTC Therapeutics to Host Conference Call to Discuss Third Quarter 2025 Financial Results
2025-10-01 16:30U:PTCTNews ReleasePTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-08-21 08:00U:PTCTNews ReleasePTC Therapeutics to Participate at Upcoming Investor Conferences
2025-08-19 08:00U:PTCTNews ReleasePTC Therapeutics Receives Complete Response Letter for Vatiquinone NDA
2025-08-07 16:01U:PTCTNews ReleasePTC Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
2025-07-28 16:19U:PTCTNews ReleasePTC Therapeutics Announces FDA Approval of Sephience(TM) (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU)